Economics of Team-Based Care for Blood Pressure Control: Updated Community Guide Systematic Review.

Area of Science:

• Health Economics
• Public Health
• Cardiovascular Disease Management

Background:

• High blood pressure (hypertension) remains a significant global health challenge.
• Effective and economically viable interventions are crucial for hypertension control.
• Team-based care models have emerged as a promising strategy for managing chronic conditions.

Purpose of the Study:

• To evaluate the recent evidence on the cost-effectiveness of team-based care for hypertension control.
• To analyze economic data from studies conducted in the U.S. and other high-income countries.
• To compare intervention costs, healthcare cost changes, and net costs associated with team-based care.

Main Methods:

• Systematic search for economic evaluations of team-based care for hypertension published between January 2011 and January 2021.
• Inclusion of studies from the U.S. and other high-income countries.
• Analysis of intervention costs, healthcare cost savings, net costs, and cost per quality-adjusted life year (QALY).

Main Results:

• Median intervention costs were $438/patient/year in the U.S. and $299/patient/year overall.
• Median net costs were $439/patient/year in the U.S. and $133/patient/year overall.
• Median cost per QALY gained was $12,897 for U.S. studies and $15,202 for all studies, both below the $50,000 benchmark.

Conclusions:

• Team-based care for hypertension control demonstrates favorable cost-effectiveness in high-income countries.
• While intervention costs were higher in the U.S., the overall economic value remains positive.
• The findings support the continued implementation and expansion of team-based care models for blood pressure management.